Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B W Christman

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Chest|September 19, 1998
Lipid mediator dysregulation in primary pulmonary hypertensionB W Christman
New Horizons (Baltimore, Md.)|November 1, 1993
Antilipid mediator and antioxidant therapy in adult respiratory distress syndromeB W Christman, G R Bernard
Biomedical & Environmental Mass Spectrometry|April 1, 1989
Analysis of platelet activating factor in human saliva by gas chromatography/mass spectrometryB W Christman, I A Blair
Methods in Molecular Medicine|February 22, 2011
Quantitative analysis of f(2) isoprostanesR Dworski, B W Christman, J R Sheller
Methods in Molecular Medicine|February 22, 2011
Quantitative analysis of cyclooxygenase metabolites of arachidonic AcidR Dworski, J R Sheller, B W Christman
The American Journal of Physiology|February 11, 1995
Response of cultured human pulmonary artery endothelial cells to endotoxinB Meyrick, L C Berry, B W Christman
The American Review of Respiratory Disease|June 1, 1987
Effect of platelet-activating factor on aerosol histamine responsiveness in awake sheepB W Christman, P L Lefferts, J R Snapper
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1996
Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2L L Cuiper, P V Price, B W Christman
Chest|January 1, 1999
Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDSC T Carpenter, P V Price, B W Christman
Free Radical Biology & Medicine|November 4, 1998
F2-isoprostane generation in isolated ferret lungs after oxidant injury or ventilated ischemiaP M Becker, S P Sanders, P Price, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Chest|September 19, 1998
Lipid mediator dysregulation in primary pulmonary hypertensionB W Christman
New Horizons (Baltimore, Md.)|November 1, 1993
Antilipid mediator and antioxidant therapy in adult respiratory distress syndromeB W Christman, G R Bernard
Biomedical & Environmental Mass Spectrometry|April 1, 1989
Analysis of platelet activating factor in human saliva by gas chromatography/mass spectrometryB W Christman, I A Blair
Methods in Molecular Medicine|February 22, 2011
Quantitative analysis of f(2) isoprostanesR Dworski, B W Christman, J R Sheller
Methods in Molecular Medicine|February 22, 2011
Quantitative analysis of cyclooxygenase metabolites of arachidonic AcidR Dworski, J R Sheller, B W Christman
The American Journal of Physiology|February 11, 1995
Response of cultured human pulmonary artery endothelial cells to endotoxinB Meyrick, L C Berry, B W Christman
The American Review of Respiratory Disease|June 1, 1987
Effect of platelet-activating factor on aerosol histamine responsiveness in awake sheepB W Christman, P L Lefferts, J R Snapper
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1996
Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2L L Cuiper, P V Price, B W Christman
Chest|January 1, 1999
Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDSC T Carpenter, P V Price, B W Christman
Free Radical Biology & Medicine|November 4, 1998
F2-isoprostane generation in isolated ferret lungs after oxidant injury or ventilated ischemiaP M Becker, S P Sanders, P Price, et al.
Pageof 4